Abstract
Get full access to this article
View all access options for this article.
References
1.U.S. Food and Drug Administration . FDA continues strong support of innovation in development of gene therapy products . January 28 , 2020 . https://www.fda.gov/news-events/press-announcements/fda-continues-strong-support-innovation-development-gene-therapy-products (last accessed
January 31 , 2020
).
2.
Philippidis
A
. Sangamo CEO looks long-term toward in vivo genome editing, regulation . January 22 , 2020 . https://www.genengnews.com/gen-edge/sangamo-ceo-looks-long-term-toward-in-vivo-genome-editing-regulation/ (last accessed
January 31 , 2020
).
3.Pfizer, Inc . Pfizer reports fourth quarter and full-year 2019 results . January 28 , 2020 . https://investors.pfizer.com/investor-news/press-release-details/2020/PFIZER-REPORTS-FOURTH-QUARTER-AND-FULL-YEAR-2019-RESULTS/default.aspx (last accessed
January 31 , 2020
).
4.The Motley Fool . Pfizer, Inc (PFE) Q4 2019 earnings call transcript . January 28 , 2020 . https://www.fool.com/earnings/call-transcripts/2020/01/28/pfizer-inc-pfe-q4-2019-earnings-call-transcript.aspx (last accessed
January 31 , 2020
).
5.
Philippidis
A
. From J.P. Morgan: cell, gene therapy to drive biopharma M&A in 2020 . January 13 , 2020 . https://www.genengnews.com/topics/drug-discovery/from-jp-morgan-cell-gene-therapy-to-drive-biopharma-ma-in-2020/ (last accessed
January 31 , 2020
).
6.Generation Bio . Generation Bio announces $110 million series C financing to advance lead programs for hemophilia A and PKU . January 10 , 2020 . https://www.businesswire.com/news/home/20200110005089/en/Generation-Bio-Announces-110-Million-Series-Financing (last accessed
January 31 , 2020
).
7.bluebird bio, Inc . bluebird bio announces launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years and older with transfusion-dependent β-thalassemia who do not have β0/β0 genotype . January 13 , 2020 . http://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-launch-germany-zynteglotm-autologous-cd34 (last accessed
January 31 , 2020
).
8.AGTC . AGTC reports positive six-month data from its ongoing Phase 1/2 clinical trial in X-linked retinitis pigmentosa . January 9 , 2020 . http://ir.agtc.com/news-releases/news-release-details/agtc-reports-positive-six-month-data-its-ongoing-phase-12 (last accessed
January 31 , 2020
).
9.
Philippidis
A
. AGTC plans pivotal trial for XLRP gene therapy . January 9 , 2020 . https://www.genengnews.com/gen-edge/agtc-plans-pivotal-trial-for-xlrp-gene-therapy/ (last accessed
January 31 , 2020
).
10.U.S. Securities and Exchange Commission . Form S-1 Registration Statement of Passage Bio, Inc . Filed February 3 , 2020 . https://www.sec.gov/Archives/edgar/data/1787297/000104746920000652/a2240560zs-1.htm#cg70401_risk_factors (last accessed
February 3 , 2020
).